Travere Therapeutics, Inc.
TVTX
37 insider filings · Latest: May 5, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Apr 2 9:55 PM | Elizabeth E ReedChief Legal Officer and GC | Sale | 10,000 | $30.00 | $300.0K | 105,211(D) | View → |
| Apr 1, 2026 | Apr 1 8:13 PM | Dube Eric M | Proposed Sale | 60,000 | $30.93 | $1.9M | — | View → |
| Apr 1, 2026 | Apr 1 8:06 PM | ELIZABETH REED | Proposed Sale | 10,000 | $30.00 | $300.0K | — | View → |
| Mar 16, 2026 | Mar 18 8:05 PM | Elizabeth E ReedChief Legal Officer and GC | Sale | 10,000 | $28.09 | $280.9K | 105,211(D) | View → |
| Mar 16, 2026 | Mar 16 8:20 PM | ELIZABETH REED | Proposed Sale | 10,000 | $28.09 | $280.9K | — | View → |
| Feb 20, 2026 | Feb 24 9:05 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 60,000 | $30.10 | $1.8M | 432,886(D) | View → |
| Feb 20, 2026 | Feb 20 9:49 PM | Dube Eric M | Proposed Sale | 60,000 | $30.10 | $1.8M | — | View → |
| Feb 17, 2026 | Feb 19 9:10 PM | Elizabeth E ReedChief Legal Officer and GC | Sale | 10,000 | $27.83 | $278.3K | 105,211(D) | View → |
| Feb 17, 2026 | Feb 17 9:30 PM | ELIZABETH REED | Proposed Sale | 10,000 | $27.83 | $278.3K | — | View → |
| Feb 4, 2026 | Feb 5 9:05 PM | Jula InrigCHIEF MEDICAL OFFICER | Sale | 1,779 | $32.21 | $57.3K | 105,706(D) | View → |
| Feb 4, 2026 | Feb 5 9:05 PM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Sale | 1,745 | $32.19 | $56.2K | 111,226(D) | View → |
| Feb 4, 2026 | Feb 5 9:05 PM | Elizabeth E ReedChief Legal Officer and GC | Sale | 2,994 | $32.18 | $96.4K | 105,211(D) | View → |
| Feb 4, 2026 | Feb 4 9:07 PM | ELIZABETH REED | Proposed Sale | 2,994 | $32.18 | $96.4K | — | View → |
| Feb 4, 2026 | Feb 4 9:06 PM | JULA INRIG | Proposed Sale | 1,779 | $32.21 | $57.3K | — | View → |
| Feb 4, 2026 | Feb 4 9:01 PM | CHRISTOPHER CLINE | Proposed Sale | 1,745 | $32.19 | $56.2K | — | View → |
| Feb 3, 2026 | Feb 4 11:00 AM | Peter Heerma | Proposed Sale | 7,310 | $32.12 | $234.8K | — | View → |
| Feb 3, 2026 | Feb 4 2:59 AM | Elizabeth E. Reed | Proposed Sale | 7,175 | $32.12 | $230.5K | — | View → |
| Feb 3, 2026 | Feb 4 2:58 AM | Sandra Calvin | Proposed Sale | 4,333 | $32.12 | $139.2K | — | View → |
| Feb 3, 2026 | Feb 4 2:45 AM | Christopher Cline | Proposed Sale | 7,242 | $32.12 | $232.6K | — | View → |
| Feb 3, 2026 | Feb 4 2:37 AM | Jula Inrig | Proposed Sale | 6,956 | $32.12 | $223.4K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 5, 2026 | May 7 12:00 AM | Roy D. BaynesDirector | Option Exercise | 4,500 | $18.27 | 0(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Meckler Jeffrey ADirector | Option Exercise | 8,000 | $16.33 | 0(D) | View → |
| May 4, 2026 | May 7 12:00 AM | William E. RoteChief Research Officer | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | William E. RoteChief Research Officer | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Elizabeth E ReedChief Legal Officer and GC | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 24,250 | $17.96 | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Jula InrigCHIEF MEDICAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Jula InrigCHIEF MEDICAL OFFICER | Option Exercise | 24,250 | $22.40 | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 45,000 | — | 45,000(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 22,500 | — | 22,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 1, 2026 | May 4 8:27 PM | Roy D. BaynesDirector | Option Exercise | 9,750 | $6.82 | 9,750(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | LYONS GARY ADirector | Option Exercise | 8,000 | $16.33 | 0(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Roy D. BaynesDirector | Option Exercise | 32,750 | $21.38 | 6,750(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Option Exercise | 15,250 | $22.40 | 19,500(D) | View → |
| Apr 14, 2026 | Apr 16 1:47 AM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 37,500 | $19.08 | 20,000(D) | View → |
| Apr 6, 2026 | Apr 7 10:17 PM | Roy D. BaynesDirector | Option Exercise | 10,000 | $26.52 | 0(D) | View → |
Page 1 of 2
Next →